No company can match StemCyte's LifeSaver Guarantee!
With StemCyte's Hybrid model you will naturally
receive support and options at NO additional cost
If for any reason your newborn's cord blood unit fails to engraft, StemCyte's LifeSaver Guarantee will:
-
Find a replacement at no cost to parents from StemCyte's public inventory.
-
Refund All Fees.
-
Provide parents with an additional $50k.

Cord Blood & Tissue Banking
Cord Blood & Tissue Banking
Cord Blood & Tissue Banking
MaxCell®
Annual Cord Blood Plans
FDA Approved Treatments
Cord Blood Stem Cells
FDA Approved Treatments
Cord Blood Stem Cells
Cord Blood Cord blood contains a rich source of various cells including hematopoietic stem cells which form blood cells. Today, there are 80 diseases that can be treated with cord blood stem cells. Also, there are more than 100 active cord blood stem cell clinical trials worldwide investigating the treatment of various diseases like autism.
An Overview
StemCyte's Top Advantages
There are many important things to consider before choosing a company to preserve your newborn's cord blood and cord tissue. As pioneers in regenerative medicine, StemCyte knows what truly matters at every step of banking. We hope this list of our top advantages will give you the confidence in our science, products, and the people who will care for your family's future health and well-being.
An Overview
StemCyte's Top Advantages
There are many important things to consider before choosing a company to preserve your newborn's cord blood and cord tissue. As pioneers in regenerative medicine, StemCyte knows what truly matters at every step of banking. We hope this list of our top advantages will give you the confidence in our science, products, and the people who will care for your family's future health and well-being.
Cord Blood & Cord Tissue Preservation
(866) 389-4659
The Future is So Bright!
Active Clinical Trials
Today, there are 100+ active clinical trials testing the efficacy of cord blood stem cells on numerous diseases and health conditions. There are also 500+ active clinical trials using cord blood tissue. The mere volume of active clinical trials today truly demonstrates the power and potential of both cord blood and cord tissue stem cells in regenerative medicine.
StemCyte Sponsored Clinical Trials
Spinal Cord Injury / Phase II
StemCyte is the first hybrid cord blood bank to receive an FDA–approved Phase II clinical trial to treat spinal cord injuries.
StemCyte's early trials in China were so successful in treating spinal cord injury that the FDA waived the normally required Phase I clinical trial in the U.S., and proceeded to grant StemCyte the approval to start its Phase II clinical trial! The FDA's confidence in StemCyte's methodologies will speed up the clinical trial process and hopefully culminate in the FDA approving the treatment of spinal cord injury with umbilical cord blood stem cells. StemCyte is honored to receive the FDA's endorsement of our commitment to science excellence. This is the first time that the FDA has waived the need for a Phase I clinical trial in the pursuit of new treatments using UCSC.
Acute Stroke Using Cord Blood Stem Cells
To learn more about this clinical trial please visit
6
StemCyte is actively involved in six clinical trials testing cord blood stem cells in the treatment of acute and chronic stroke, cerebral palsy, autism, spinal cord injury, and cartilage repair.
StemCyte is so much more than a cord blood and cord tissue banking company. We are leading the charge in regenerative medicine through our clinical trials. When banking your baby's cord blood and cord tissue, you are truly protecting the future health of your family!

Active Clinical Trials Worldwide
Cord Blood Stem Cells
-
Spinal cord injuries
-
Autism
-
Cerebral palsy
-
Cardiovascular disorders
-
Acute stroke
-
Chronic stroke
-
Diabetes
Cord Tissue Stem Cells
-
Heart disease
-
Parkinson's disease
-
Alzheimer’s disease
-
Lung disease
-
Liver disease
-
Osteoarthritis
-
Diabetes